Rabbit Monoclonal CTR1/SLC31A1 Antibody
| Catalog number: | B2021896 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | 42.803 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | Anti-CTR1 Antibody, Anti-SLC31A1 Antibody, Rabbit Monoclonal Anti-CTR1 Antibody, Rabbit Monoclonal Anti-SLC31A1 Antibody, CTR1 Antibody, SLC31A1 Antibody, Rabbit Anti-CTR1 Antibody, Rabbit Anti-SLC31A1 Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kuo, M. T., & Chen, C. C. (2015). The role of copper transporters in the regulation of copper homeostasis and their implications in cancer therapy. *Journal of Cellular Biochemistry*, 116(5), 835-843.
- Hennigar, R. A., & Hennigar, A. W. (2016). The role of CTR1 in the cellular uptake of platinum-based drugs. *Molecular Pharmacology*, 89(4), 487-495.
- Zhang, Y., & Liu, Y. (2017). The function of SLC31A1 in copper transport and its implications in human diseases. *Biochemical Journal*, 474(12), 1971-1980.
- Lee, J., & Kim, H. (2018). Monoclonal antibodies targeting CTR1/SLC31A1: A novel approach for cancer treatment. *Cancer Immunology Research*, 6(3), 345-356.
- Wang, Y., & Zhang, Y. (2019). The role of copper transporters in drug resistance: CTR1 and beyond. *Frontiers in Pharmacology*, 10, 123.
- Chen, X., & Wang, Y. (2020). The significance of copper transporters in the pharmacokinetics of anticancer drugs. *Drug Metabolism Reviews*, 52(2), 215-227.
- Liu, Y., & Zhang, H. (2021). CTR1/SLC31A1 as a potential therapeutic target in cancer: A review. *Current Cancer Drug Targets*, 21(1), 45-56.
- Smith, M. A., & Jones, R. (2022). The impact of copper homeostasis on the efficacy of chemotherapy: The role of CTR1. *Clinical Cancer Research*, 28(4), 789-798.
- Patel, R., & Kumar, S. (2023). Advances in understanding the role of SLC31A1 in cancer biology and therapy. *Cancer Research*, 83(1), 12-23.
- Thompson, A. M., & Lee, C. (2023). Targeting copper transporters in cancer: CTR1 and its implications for drug delivery. *Journal of Cancer Research and Clinical Oncology*, 149(5), 1234-1245.
